Center Overview

Chase Medical Research, LLC, formerly known as the Clinical Research Department of Phoenix Internal Medicine Associates, LLC. is led by Joseph Soufer, MD, who specializes in Internal Medicine with a sub-specialty of Endocrinology. Dr. Soufer has practiced Internal Medicine in the Waterbury community for the past 25 years and serves as Medical Director of the clinical research department since the year 2000.

Chase Medical Research, LLC is affiliated with area specialists in Neurology, Psychology, Rheumatology, Gastroenterology and Obstetrics and Gynecology. Studies have been conducted in the therapeutic areas of Women’s Health, Endocrinology, Cardiovascular, Central Nervous System, Rheumatology, Men’s Health and Metabolic Disorders. Chase Medical Research, LLC consists of partnering physicians from the following specialty groups: Phoenix Internal Medicine Associates, LLC, Digestive Disease Center of Connecticut and Leonard I.Goldstein, PsyD of the Connecticut Resource Group. All participating physicians are Board Certified in their specialty areas of medicine.

Chase Medical Research, LLC consists of 3 FTE Clinical Research Coordinators, 1 FTE Manager of Administrative Services, 1 FTE Patient Recruitment Coordinator, 1 FTE Document Specialist/Laboratory Assistant and 1 FTE Office Assistant. All research is conducted in our Waterbury facility. We offer a comfortable, efficient and a private workplace for CRA’s with access to phone, fax and modem. Hotels are conveniently located nearby.

Facility Description

Chase Medical Research, LLC- offers outpatient research at present.

On-Site Equipment:

• Secure drug storage (locked, temperature-controlled cabinets)
• Secure record storage
• Sphygmomanometers
• ECG
• (3)-20 degree freezers
• Dedicated Refrigerator
• Full Laboratory Services
• Centrifuge
• Phlebotomy
• DEXA (Lunar)
• Work area for CRA’S
• Conference Room
• Crash Cart + CPR/AED certified staff
• Exam rooms
• PFT Spirometer
• Access to dry ice
• Access to Radiological Services
• Access to Hologic DEXA Services

Investigator Experience

Medical Director: Joseph Soufer, MD

Physicians (Principal/Sub-Investigators):

• Joseph Soufer, MD
  Board Certified in Internal Medicine
  Specializing in Endocrinology
  Certified In Bone Densitometry
• Leonardi Koliani, MD
  Board Certified in Internal Medicine
  Medical Director and/or Attending Physician at approximately 12 local Convalescent Homes/Extended Care Facilities
• Arthur L. Lebowitz, MD
  Board Certified in Internal Medicine
  Certified In Bone Densitometry
• Joseph DeLuca, MD
  Board Certified in Internal Medicine
• Peter G. Levinson, MD
  Board Certified in Internal Medicine
• Stephen R. Rubenstein, MD, FACP
  Board Certified in Internal Medicine

Staff Expertise

Diane Rabideau, RN, IV-C, CRC
Director of Clinical Operations
4 years of Clinical Research Experience

Staci M. Berardi, MA, CRC
Study Coordinator
2 years of Clinical Research Experience

Siobhan Reilly, CRC
Study Coordinator
2½ years of Clinical Research Experience

Cheryl J. Nickles
Patient Recruitment Coordinator
3 years of Clinical Research Experience

Deborah Pillis
Document Specialist/Laboratory Assistant
3 years of Clinical Research Experience

Kimberly R. Vasquez
Manager of Administrative Services
3 years of Clinical Research Experience

Christine Ludovicy
Office Assistant
1 year of Clinical Research Experience

Patient Demographics

Other Information

Chase Medical Research, LLC uses a Central IRB and has access to Electronic Medical Records for Phoenix Internal Medicine, LLC. Database queries are feasible in a short period of time in order to pre-identify subjects for a rapid turn-around. The Research Personnel are familiar with numerous Central IRB’s and their submission requirements.

Contact Information

Diane Rabideau, RN, IV-C, CRC
Director of Clinical Operations
Chase Medical Research, LLC
500 Chase Parkway - 3rd Floor
Waterbury, CT 06708
USA
Phone: 203-419-4420
Fax: 203-465-7924
EMail: Medical_research@chasemr.com
Web Site: http://www.chasemr.com

Currently Enrolling Trials

• A Dose-Response Efficacy and Safety Study of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects with Gastroesophageal Reflux Disease (GERD) who are Incomplete Responders to a Proton Pump Inhibitor (PPI).
• A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide When Used in Combination with Metformin in Subjects with Type 2 Diabetes.
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Linaclotide Administered Orally for 12 Weeks Followed by a 4-Week Randomized Withdrawal Period in Patients with Irritable Bowel Syndrome with Constipation.
• A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine as Compared with the Combination of Insulin Glargine and Preprandial Lispro Insulin in Subjects With Type 2 Diabetes Mellitus.

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the E-mail form below. A representative from the research center will then follow up with you.